THE CAPITAL BEHIND THE DEAL

OMass Therapeutics

United Kingdom · 2026-10-15 · Series C

US$310MAnnounced transaction total, not an investor contribution

Oxford, United KingdomCompany location

5 mappedSource-linked participants; coverage may be partial

Lead / transaction context: Bain Capital Life Sciences, Forbion and Novo Holdings
Recorded investor context: New participants also include Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences. Returning investors: Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures, British Business Bank and University of Oxford.
Public participation: Recorded · Equity
Sector: Biotechnology

Explore this deal on the map →

Source-linked participants

Forbion

Naarden, Netherlands → OMass Therapeutics

Recorded participation

Participation source ↗ · Investor location source ↗

Janus Henderson

London, United Kingdom → OMass Therapeutics

Recorded participation

Participation source ↗ · Investor location source ↗

GV

San Francisco, United States → OMass Therapeutics

Recorded participation

Participation source ↗ · Investor location source ↗

Oxford Science Enterprises

Oxford, United Kingdom → OMass Therapeutics

Recorded participation

Participation source ↗ · Investor location source ↗

British Business Bank

Sheffield, United Kingdom → OMass Therapeutics

Recorded participation

Participation source ↗ · Investor location source ↗

Sources and limits

Open announcement source ↗ · Company location source ↗

Lines show source-supported participation between approximate city-centre locations. An investor point may represent a disclosed office or a fund manager, not the fund domicile or payment origin. Individual contributions are disclosed only where separately sourced; the round total is never divided between investors. The mapped participants may be a subset of the announced syndicate. Source checked 2026-10-23T15:06:37.958Z.

Share on LinkedIn ↗Download branded PNG

Follow Capital Flows on LinkedIn ↗

Related in our coverage

United Kingdom · 2026-10-14

Salience Labs

US$125M

Series B · announced transaction total

Recorded public participation. Explore the role and round-specific sources.

Source ↗

United Kingdom · 2026-10-08

TrueLayer

US$27M

Other · announced transaction total

Recorded public participation. Explore the role and round-specific sources.

Source ↗

United Kingdom · 2026-09-14

Open Cosmos

€300M

Series C · announced transaction total

Recorded public participation. Explore the role and round-specific sources.

Source ↗

Explore this announcement week →

Explore the wider context

Public capital in venture rounds →

Follow the recorded investors

British Business Bank → · Forbion → · GV → · Janus Henderson → · Oxford Science Enterprises →